CXCL8 and cancer: As a result, the down-regulation of these pro-inflammatory molecules, IL6 and CXCL8 in cancer cells could perhaps perturb their intrinsic metabolic pathways, as well as help these cells evade the immune response, which potentially leads to a survival advantage of these malignant cells33, 34.